Toxic shock syndrome

被引:0
作者
Tyll, T. [1 ,2 ]
Bilkova, M. [1 ,2 ]
Revinova, A. [1 ,2 ]
Mueller, M. [1 ,2 ]
Curdova, M. [3 ]
Zlamal, M. [2 ,4 ]
Holub, M. [2 ,4 ]
机构
[1] 1 LF UK, Klin Anesteziol Resuscitace & Intenzivni Med, Prague 16902 6, Czech Republic
[2] Vojenska Fak Nemocnice Praha, Ustredni Vojenska Nemocnice, Prague, Czech Republic
[3] Vojenska Fak Nemocnice Praha, Ustredni Vojenska Nemocnice, Oddeleni Klin Mikrobiol, Prague, Czech Republic
[4] 1 LF UK, Klin Infekcnich Nemoci, Prague, Czech Republic
来源
EPIDEMIOLOGIE MIKROBIOLOGIE IMUNOLOGIE | 2015年 / 64卷 / 04期
关键词
toxic shock syndrome; toxigenic strain; toxin; superantigen; INTRAVENOUS IMMUNOGLOBULIN THERAPY; ANTIBIOTICS; EXPRESSION;
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The authors present an up-to-date review of toxic shock syndrome (TSS) - a life-threatening condition where toxins of the Gram-positive bacteria Staphyloccocus aureus and Streptococcus pyogenes play a key role in the pathogenesis. The authors provide insight into the epidemiology and pathogenesis of the disease and point out the relevant patient history data and clinical signs and symptoms that may indicate progression of TSS. Last but not least, the state of the art diagnostic and therapeutic approaches to early and full blown TSS are summarized. Case reports are presented to illustrate two different etiological forms of this relatively rare nosological entity.
引用
收藏
页码:210 / 220
页数:11
相关论文
共 32 条
[1]   ANTIBODY-RESPONSES TO TOXIC-SHOCK SYNDROME (TSS) TOXIN BY PATIENTS WITH TSS AND BY HEALTHY STAPHYLOCOCCAL CARRIERS [J].
BONVENTRE, PF ;
LINNEMANN, C ;
WECKBACH, LS ;
STANECK, JL ;
BUNCHER, CR ;
VIGDORTH, E ;
RITZ, H ;
ARCHER, D ;
SMITH, B .
JOURNAL OF INFECTIOUS DISEASES, 1984, 150 (05) :662-666
[2]   CLINICAL AND BACTERIOLOGICAL OBSERVATIONS OF A TOXIC SHOCK-LIKE SYNDROME DUE TO STREPTOCOCCUS-PYOGENES [J].
CONE, LA ;
WOODARD, DR ;
SCHLIEVERT, PM ;
TOMORY, GS .
NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (03) :146-149
[3]   Differences in potency of intravenous polyspecific immunoglobulin G against streptococcal and staphylococcal superantigens:: Implications for therapy of toxic shock syndrome [J].
Darenberg, J ;
Söderquist, B ;
Normark, BH ;
Norrby-Teglund, A .
CLINICAL INFECTIOUS DISEASES, 2004, 38 (06) :836-842
[4]  
Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI DOI 10.1007/s00134-012-2769-8
[5]  
Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1097/CCM.0B013E31827E83AF, DOI 10.1007/s00134-012-2769-8]
[6]   Toxic Shock Syndrome and Persistent Immune Activation in an HIV-Positive Patient [J].
Holub, Michal ;
Arientova, Simona ;
Jilich, David ;
Davidova, Alzbeta ;
Beran, Ondrej ;
Rozsypal, Hanus .
CURRENT HIV RESEARCH, 2013, 11 (04) :321-325
[7]   Staphylococcal toxic shock syndrome - Suspicion and prevention are keys to control [J].
Issa, NC ;
Thompson, RL .
POSTGRADUATE MEDICINE, 2001, 110 (04) :55-+
[8]  
JACOBSON JA, 1986, ARCH OTOLARYNGOL, V112, P329
[9]   Staphylococcal Toxic Shock Syndrome Toxin-1 Induces the Translocation and Secretion of High Mobility Group-1 Protein from Both Activated T Cells and Monocytes [J].
Kalyan, Shirin ;
Chow, Anthony W. .
MEDIATORS OF INFLAMMATION, 2008, 2008
[10]   Synthetic Human Monoclonal Antibodies toward Staphylococcal Enterotoxin B (SEB) Protective against Toxic Shock Syndrome [J].
Karauzum, Hatice ;
Chen, Gang ;
Abaandou, Laura ;
Mahmoudieh, Mahta ;
Boroun, Atefeh R. ;
Shulenin, Sergey ;
Devi, V. Sathya ;
Stavale, Eric ;
Warfield, Kelly L. ;
Zeitlin, Larry ;
Roy, Chad J. ;
Sidhu, Sachdev S. ;
Aman, M. Javad .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (30) :25203-25215